{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05018767",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SC-11-ATG-12-01"
      },
      "Organization": {
        "OrgFullName": "The Foundation for Orthopaedics and Regenerative Medicine",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty",
      "OfficialTitle": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 2022",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "November 2025",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 2025",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 18, 2021",
      "StudyFirstSubmitQCDate": "August 19, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 24, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 4, 2022",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 5, 2022",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "The Foundation for Orthopaedics and Regenerative Medicine",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Aging Frailty",
      "DetailedDescription": "Studies have shown that stem cell treatment is safe and efficacious for the treatment of Aging Frailty. This patient funded trial aims to study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells (UC-MSCs) for the treatment of Frailty. Patients with Frailty will receive a single intravenous infusion of UC-MSCs. The total dose will be 100 million cells. Patients will be evaluated within one month pre treatment and at 1, 6, 12, 24, 36, and 48 months post treatment for safety and efficacy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Frailty"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Frailty",
          "stem cell treatment",
          "Anti Aging"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Treatment Group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Single intravenous infusion of 100 million cells",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: AlloRx"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "AlloRx",
            "InterventionDescription": "cultured allogeneic adult umbilical cord derived mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Treatment Group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety (adverse events)",
            "PrimaryOutcomeDescription": "Clinical monitoring of possible adverse events or complications",
            "PrimaryOutcomeTimeFrame": "Four year follow-up"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of Aging Frailty\nUnderstanding and willingness to sign a written informed consent document\n\nExclusion Criteria:\n\nActive infection\nActive cancer\nChronic multisystem organ failure\nPregnancy\nClinically significant abnormalities on pre-treatment laboratory evaluation\nMedical condition that would (based on the opinion of the investigator) compromise patient's safety.\nContinued drug abuse\nPre-menopausal women not using contraception\nPrevious organ transplant\nHypersensitivity to sulfur",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Chadwick Prodromos, MD",
            "OverallOfficialAffiliation": "The Foundation for Orthopaedics and Regenerative Medicine",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Medical Surgical Associates Center",
            "LocationStatus": "Recruiting",
            "LocationCity": "St. John's",
            "LocationCountry": "Antigua and Barbuda",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Chadwick Prodromos, M.D.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "8476996810",
                  "LocationContactEMail": "care@thepsci.com"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "28977399",
            "ReferenceType": "background",
            "ReferenceCitation": "Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Da Fonseca M, Golpanian S, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Green G, Oliva AA, Hare JM. Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1513-1522. doi: 10.1093/gerona/glx137."
          },
          {
            "ReferencePMID": "28444181",
            "ReferenceType": "background",
            "ReferenceCitation": "Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1505-1512. doi: 10.1093/gerona/glx056."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000073496",
            "ConditionMeshTerm": "Frailty"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M1175",
            "ConditionBrowseLeafName": "Frailty",
            "ConditionBrowseLeafAsFound": "Frailty",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}